DreaMed Diabetes Overview

  • Founded

  • 2014

Founded
  • Status

  • Private

  • Employees

  • 36

Employees
  • Latest Deal Type

  • Early Stage VC

  • Latest Deal Amount

  • $1.21M

  • Investors

  • 9

DreaMed Diabetes General Information

Description

Developer of a diabetes management system designed to optimize intensive insulin therapy. The company's system uses event-driven machine learning and logic technology in order to process multiple personalized parameters such as insulin delivery data, glucose readings, meal data, and optimized insulin dosing treatment plan, enabling clients to improve their living standards and down their overall treatment costs.

Contact Information

Website
www.dreamed-diabetes.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Monitoring Equipment
Other Industries
Other Healthcare Technology Systems
Primary Office
  • 5 Mota Gur Street
  • Petah Tikva 4952701
  • Israel

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

DreaMed Diabetes Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC 18-Sep-2017 $1.21M 00.000 Completed Generating Revenue
3. Early Stage VC (Series A) 25-Jul-2016 00.00 00.00 000.00 Completed Generating Revenue
2. Grant 03-Feb-2016 $3.4M $2M Completed Generating Revenue
1. Angel (individual) 06-Apr-2015 $2M $2M 000.00 Completed Generating Revenue
To view DreaMed Diabetes’s complete valuation and funding history, request access »

DreaMed Diabetes Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a diabetes management system designed to optimize intensive insulin therapy. The company's system uses even
Monitoring Equipment
Petah Tikva, Israel
36 As of 2022
00.000
0000000000 0 00.000

000000

ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et do
0000000000 000000000
San Diego, CA
00 As of 0000
000.00
000 0000-00-00
00000000000 000.00

000000

consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nu
0000000000 000000000
Salem, NH
000 As of 0000
00000
000000 - 000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

DreaMed Diabetes Competitors (16)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
GlySens Venture Capital-Backed San Diego, CA 00 000.00 00000000000 000.00
00000000 00000000 Venture Capital-Backed Salem, NH 000 00000 000000 - 000 00000
000000000 Formerly Accelerator/Incubator backed London, United Kingdom 00 000000&0
0000000 0000000 Private Equity-Backed Fremont, CA 00 00000 00000000 00000
0000 000000000000 Corporation Woodbridge Township, NJ 00 000.00 000000000. 0 000.00
You’re viewing 5 of 16 competitors. Get the full list »

DreaMed Diabetes Patents

  • 20

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 2

    Granted

  • 1

    Pending

  • 000

    Expiring in next 12 mo

DreaMed Diabetes Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210193285-A1 A system and method for use in disease treatment management Pending 19-Oct-2017 000000000
AU-2010302266-A1 Monitoring device for management of insulin delivery Abandoned 30-Sep-2009 000000000
JP-2013526887-A Monitoring device for insulin delivery Granted 30-Sep-2009 000000000 0
JP-5728767-B2 Monitoring system, method and computer program for management of insulin delivery Active 30-Sep-2009 000000000
CA-2776007-A1 Monitoring device for mangement of insulin delivery Abandoned 30-Sep-2009 G16H20/17
To view DreaMed Diabetes’s complete patent history, request access »

DreaMed Diabetes Executive Team (13)

Name Title Board Seat Contact Info
Eran Atlas Co-Founder & Chief Executive Officer
Revital Nimri Chief Medical R&D Officer, Co-Founder & Clinical Advisor
Eran Agmon Chief Product Officer
Thomas Danne Co-Founder & Clinical Advisor
Tadej Battelino Co-Founder & Clinical Advisory Team Member
You’re viewing 5 of 13 executive team members. Get the full list »

DreaMed Diabetes Board Members (1)

Name Representing Role Since
Moshe Phillip Self Co-Founder, Chief Science Officer & Chairman 000 0000
To view DreaMed Diabetes’s complete board members history, request access »

DreaMed Diabetes Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

DreaMed Diabetes Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
A-Labs Corporation Minority 000 0000 000000 0
Mark Suss Angel (individual) Minority 000 0000 000000 0
OurCrowd Venture Capital Minority 000 0000 000000 0
Norma Investments Venture Capital Minority 000 0000 000000 0
The Millhouse Asset Manager Minority 000 0000 000000 0
You’re viewing 5 of 9 investors. Get the full list »

Ready to get started?

Request a free trial